PT, INR and aPTT: normal and therapeutic values

Normal INR is typically 0.8–1.1, PT 11.0–13.0 seconds and aPTT 25–35 seconds. On warfarin the INR target is usually 2.0–3.0; on a heparin infusion the aPTT target is set by the hospital protocol. Judge anticoagulated patients against their target, not the normal range. Follow your facility's ranges.

Try it now

Normal or therapeutic? · free, no sign-up

NEW RESULT

82-year-old female. On warfarin for a DVT. Bleeding gums and new dark stools.

Medswarfarin 7.5 mg PO dailyacetaminophen PRN
TestResult
INR7.4
Typical adult ranges; labs vary. Follow your facility's reference ranges. Educational practice only.

What is the nurse's priority?

Coagulation (typical adult, not anticoagulated)

TestTypical adult rangeCritical (Labs Drills list)
Prothrombin time11.0–13.0 seconds–
INR0.8–1.1above 5.0
Activated partial thromboplastin time25–35 secondsabove 100 seconds
Platelets150,000–400,000/mm³below 20,000/mm³ or above 1,000,000/mm³

Typical adult ranges; labs vary. Follow your facility's reference ranges and policies.

Normal versus therapeutic

Without anticoagulation, INR is 0.8–1.1 and aPTT 25–35 seconds. Patients on anticoagulants are kept above normal on purpose: an INR of 2.5 on warfarin for atrial fibrillation is on target, not "high". An INR of 1.1 on warfarin is normal for a healthy person but below that patient's target.

Labs Drills uses an INR target of 2.0–3.0 for atrial fibrillation and DVT. For heparin infusions, the item always states the protocol's aPTT target, because protocols differ.

Warfarin (PT/INR)

INR critical above 5.0 in this list. Above target without bleeding: assess for bleeding, hold the dose and notify the provider. Critical INR with bleeding: hold warfarin, notify immediately and anticipate vitamin K (and sometimes prothrombin complex concentrate). Below target: report it; the patient is not protected against clots. Nurses don't change warfarin doses.

Heparin (aPTT)

aPTT critical above 100 seconds in this list. Above the protocol target: adjust or hold per protocol, assess for bleeding and notify. With significant bleeding, the antidote is protamine sulfate. Vitamin K reverses warfarin, not heparin, and protamine reverses heparin, not warfarin.

Bleeding assessment on anticoagulants

Before giving any anticoagulant dose, check the most recent INR or aPTT, the platelet count and the time of the last dose, and look for signs of bleeding; if any of these are out of line, hold and ask before you give. Assess every anticoagulated patient for bleeding: gums, nose, urine, stool (black or bloody), wounds and IV sites, bruising, and a new headache or change in consciousness (possible intracranial bleeding). Report any new bleeding with the most recent INR or aPTT.

Teach patients on warfarin to keep vitamin K intake consistent rather than avoid it, to avoid new over-the-counter drugs and supplements without checking (many interact, including NSAIDs and some antibiotics), to use a soft toothbrush and electric razor, and to keep every INR appointment.

Drug interactions that change the INR

A sudden INR rise in a patient on a stable warfarin dose often means something changed: a new interacting drug (sulfamethoxazole-trimethoprim is a classic), less vitamin K in the diet, illness or liver problems. A fall can follow missed doses or more dietary vitamin K. Report the result together with what changed.

Heparin infusion monitoring

Weight-based heparin protocols set an aPTT (or anti-Xa) target and tell the nurse how to adjust the infusion at each check. Draw the sample from the arm without the heparin infusion, at the time the protocol states, and follow the protocol's table exactly. Heparin is an ISMP high-alert medication: many hospitals require an independent double-check of rate changes.

Watch the platelet count on heparin too (range 150,000–400,000/mm³): a fall of more than half after 5–10 days suggests heparin-induced thrombocytopenia.

Key points to remember

Normal INR 0.8–1.1, PT 11.0–13.0 seconds, aPTT 25–35 seconds.

Warfarin target INR is usually 2.0–3.0; judge anticoagulated patients against their target.

Heparin targets come from the hospital protocol; follow its table exactly.

Vitamin K reverses warfarin; protamine reverses heparin.

With any new bleeding: hold per protocol, assess, notify and anticipate reversal.

How coagulation values show up on exams

Coagulation questions test whether you compare the value with the right yardstick. For a patient not on anticoagulants, use the normal range (INR 0.8–1.1, aPTT 25–35 seconds). For a patient on warfarin, use the target (usually 2.0–3.0). For a patient on a heparin infusion, use the protocol target stated in the question.

The common distractors are: calling a therapeutic INR "high", missing a sub-therapeutic INR because it looks normal, giving a heparin bolus when the aPTT is above target, and choosing the wrong antidote (vitamin K for heparin, protamine for warfarin).

When bleeding is present, safety comes first: stop or hold the anticoagulant per protocol, assess, notify and anticipate reversal. In this list INR is critical above 5.0 and aPTT above 100 seconds.

Worked examples

INR on target

Warfarin for atrial fibrillation; INR 2.5.

  1. Above the normal 0.8–1.1, but within the target 2.0–3.0.
  2. No change beyond routine monitoring.
  3. Calling it "high" is a classic mistake.

INR above target

Warfarin for atrial fibrillation; INR 4.2; no bleeding.

  1. Above target, below the critical 5.0.
  2. Hold the warfarin, check for bleeding, notify the provider.
  3. Vitamin K needs an order and is usually for higher INRs or bleeding.

aPTT far above target

Heparin infusion, protocol target 60–80 seconds; aPTT 125 seconds; oozing at the IV site.

  1. Above the critical 100 seconds.
  2. Hold the heparin per protocol, assess for bleeding, notify the provider.
  3. Anticipate protamine if bleeding is significant.

Common mistakes

Normal range for an anticoagulated patient

Compare with the target, not the normal range.

Wrong antidote

Vitamin K for warfarin; protamine for heparin.

Heparin bolus for a high aPTT

A bolus is for a value below target.

Changing the warfarin dose yourself

Report; the provider decides.

Frequently asked questions

What is a normal INR?

Typically 0.8–1.1 in someone not on an anticoagulant.

What is the therapeutic INR on warfarin?

Usually 2.0–3.0 for atrial fibrillation and DVT/PE; some conditions use other targets set by the provider.

What is a normal aPTT?

Typically 25–35 seconds; on heparin the target is set by your hospital's protocol.

What is the antidote for warfarin?

Vitamin K (and sometimes prothrombin complex concentrate), as ordered.

What is the antidote for heparin?

Protamine sulfate, as ordered.

Why is a normal INR a problem for a patient on warfarin?

Because the goal on warfarin is usually 2.0–3.0. A normal INR means the patient is not anticoagulated enough and is not protected against clots or stroke, so report it to the provider rather than treating it as reassuring.

Practice next

References

  1. MedlinePlus: Prothrombin time (PT/INR)medlineplus.gov/lab-tests/prothrombin-time-test-and-inr-ptin
  2. Holbrook A et al. Evidence-Based Management of Anticoagulant Therapy (CHEST 2012). Chest 2012;141(2 Suppl):e152S–e184Sdoi.org/10.1378/chest.11-2295
  3. Kearon C et al. Antithrombotic Therapy for VTE Disease (CHEST 2012). Chest 2012;141(2 Suppl):e419S–e496Sdoi.org/10.1378/chest.11-2301
  4. Cleveland Clinic Laboratories: Critical and urgent valuesclevelandcliniclabs.com/laboratory-resources/policies-proced
  5. MedlinePlus: Partial thromboplastin time (PTT)medlineplus.gov/ency/article/003653.htm

Educational practice only; not a clinical decision tool. Typical adult ranges; labs vary. Follow your facility's reference ranges and policies. NCLEX is a registered trademark of NCSBN, used descriptively; Clinical Drills is not affiliated with NCSBN. Facts are summarised from the sources above; no text is reproduced.